HOSPITAL FOR SPECIAL SURGERY, RADIUS VENTURES AND ELRON ELECTRONICS LEAD $18 MILLION FINANCING ROUND FOR IMPLIANT

Impliant, a developer of novel posterior motion-preservation and cartilage-protection devices for spine and joint arthroplasty, has secured more than $18 million in Series C financing from a group of leading financial and strategic investors. New investors HSS Ventures, an affiliate of the Hospital for Special Surgery, Radius Ventures and Elron Electronic Industries participated in the round alongside Impliant's existing investors -- Advent International, Gemini Israel Funds and InnoMed Ventures.

BioSpace (http://biospace.com/news_story.cfm?StoryID=18645720&full=1)